Skip to main content
Signal8

Jones William Benton

SEC insider (Form 3/4/5 filer). CIK 0001664506. Officer at Corvus Pharmaceuticals, Inc. (CRVS). 3 reported Form 4/5 transactions since Sep 2024; latest on Dec 4, 2025. Located in BURLINGAME, CA.

Companies Jones William Benton has filed insider reports for

  • Corvus Pharmaceuticals, Inc. (CRVS): Officer, See Remarks
Jones William Benton profile photo

Jones William Benton

CIK: 0001664506

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (33.3%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Corvus Pharmaceuticals, Inc. logo
CRVS

Corvus Pharmaceuticals, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Corvus Pharmaceuticals, Inc. logo
    CRVS

    Corvus Pharmaceuticals, Inc.

    Dec 4, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    400K shares-
  • Corvus Pharmaceuticals, Inc. logo
    CRVS

    Corvus Pharmaceuticals, Inc.

    Jun 4, 2025
    Exercise
    Direct
    19.4K shares at avg. $3.50$68K
  • Corvus Pharmaceuticals, Inc. logo
    CRVS

    Corvus Pharmaceuticals, Inc.

    Dec 20, 2024
    Award

    Stock Option (Right to Buy)

    Direct
    300K shares-

1-3 of 3